[BSX] Boston Scientific Corporation


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 21.81 Change: 0.15 (0.69%)
Ext. hours: Change: 0 (0%)

chart BSX

Refresh chart

Strongest Trends Summary For BSX

BSX is in the medium-term up 17% in 2 months. In the long-term up 49% above S&P in 1 year and up 409% in 8 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr

Fundamental Ratios
Shares Outstanding EPS0.73 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.61% Sales Growth - Q/Q-6.31% P/E38.01
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-1.54% ROE-3.89% ROI-1.94%
Current Ratio1.29 Quick Ratio0.91 Long Term Debt/Equity5.3 Debt Ratio0.38
Gross Margin70.26% Operating Margin-6.43% Net Profit Margin-3.43% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-94 M Cash From Investing Activities-51 M Cash From Operating Activities-197 M Gross Profit1.3 B
Net Profit102 M Operating Profit219 M Total Assets17.12 B Total Current Assets3.77 B
Total Current Liabilities1.94 B Total Debt5.11 B Total Liabilities10.54 B Total Revenue1.84 B
Technical Data
High 52 week40.52 Low 52 week26.11 Last close39.99 Last change-1.31%
RSI72.1 Average true range0.77 Beta0.89 Volume4.25 M
Simple moving average 20 days2.63% Simple moving average 50 days8.75% Simple moving average 200 days13.73%
Performance Data
Performance Week-0.05% Performance Month7.41% Performance Quart17.44% Performance Half16.01%
Performance Year51.02% Performance Year-to-date13.16% Volatility daily1.04% Volatility weekly2.33%
Volatility monthly4.77% Volatility yearly16.53% Relative Volume246.39% Average Volume7.5 M
New High New Low


2019-03-21 11:45:13 | Why An FDA Probe Is Rocking The Boat For These Medical Device Makers

2019-03-21 09:53:01 | Abbott's ABT HeartMate 3 Pump Study Shows Favorable Results

2019-03-21 09:52:01 | Edwards Lifesciences Presents Positive Partner 3 Trial Data

2019-03-20 11:05:03 | Medtronic MDT Releases Encouraging Evalut TAVR Result

2019-03-19 12:21:04 | Boston Scientific BSX Rides on Acquisitions, Innovation

2019-03-19 12:19:04 | Boston Scientific's EP Arm Gets a Lift From Study Success

2019-03-18 17:17:00 | Dow Adds 65 Points as Markets Look Ahead to the Fed Meeting

2019-03-18 15:04:44 | BofA Lowers Boston Scientific Revenue Estimates On FDA Warning, But Keeps Buy Rating

2019-03-17 11:00:00 | Late-breaking Clinical Trial Highlights Positive Safety and Efficacy Data for the LUMINIZE™ RF Balloon Catheter

2019-03-14 09:43:01 | Boston Scientific's WATCHMAN FLX LAAC Device Gets CE Mark

2019-03-12 10:24:43 | See what the IHS Markit Score report has to say about Boston Scientific Corp.

2019-03-11 13:41:42 | Mass. firms riding bull market to nearly $1 trillion in gains

2019-03-11 07:00:00 | Boston Scientific Announces Scheduled Data at EHRA 2019 Congress

2019-03-08 09:30:02 | Boston Scientific BSX Up 1.9% Since Last Earnings Report: Can It Continue?

2019-03-04 15:13:31 | Healthcare ETF Keeps Hitting New Highs

2019-03-01 10:00:30 | Two under-the-radar health-care stocks are trading at record highs

2019-03-01 08:08:00 | What Should We Expect From Boston Scientific Corporation’s NYSE:BSX Earnings Over The Next Few Years?

2019-02-28 07:30:00 | Report: Exploring Fundamental Drivers Behind Boston Scientific, United Insurance, MPLX LP, Arthur J. Gallagher, Axis Capital, and Bemis — New Horizons, Emerging Trends, and Upcoming Developments

2019-02-27 09:30:00 | Boston Scientific to Participate in the Cowen and Company 39th Annual Healthcare Conference

2019-02-25 16:52:00 | Boston Scientific Completes $4.3 Billion Offering of Senior Notes and Issues Redemption Notice for its 2020 Notes

2019-02-21 20:29:52 | Nevro Corp NVRO Q4 2018 Earnings Conference Call Transcript

2019-02-21 18:45:00 | Boston Scientific Prices $4.3 Billion of Senior Notes

2019-02-21 12:21:07 | Boston Scientific Corporation -- Moody's assigns Baa2 rating to Boston Scientific's notes

2019-02-21 10:30:02 | Here Are the Key Growth Catalysts for Boston Scientific in 2019

2019-02-21 09:00:31 | Will Boston Scientific or Abbott Report Higher Margins?

2019-02-21 08:00:00 | The Future Is Now; Med Tech That’s Changing Lives

2019-02-21 07:31:31 | Boston Scientific or Abbott: Who Is Controlling Expenses Better?

2019-02-20 15:02:12 | Boston Scientific spent $800M to settle mesh implant lawsuits last year

2019-02-20 11:05:19 | Boston Scientific or Abbott: A Look at Expected EPS Growth

2019-02-20 09:35:17 | Boston Scientific or Abbott: Who Will Report More Revenue Growth?

2019-02-20 08:04:25 | What Analysts Recommend for Boston Scientific and Abbott

2019-02-19 18:48:10 | Boston Scientific Corp BSX Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-02-14 09:30:00 | Boston Scientific to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-14 09:07:35 | BSX is Breaking Out for the First Time Since September 2018

2019-02-13 08:25:01 | Boston Scientific Benefits From New Buyouts & Product Launch

2019-02-12 15:18:08 | Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp

2019-02-09 08:04:26 | Is Boston Scientific Corporation NYSE:BSX Investing Effectively In Its Business?

2019-02-08 08:00:34 | See what the IHS Markit Score report has to say about Boston Scientific Corp.

2019-02-07 16:43:09 | Bright Near-Term Outlook for Medical Instruments Industry

2019-02-07 09:30:02 | Company News For Feb 7, 2019

2019-02-07 07:59:08 | 3 Big Stock Charts for Thursday: FirstEnergy, Boston Scientific and Mondelez

2019-02-06 19:48:43 | Boston Scientific BSX Q4 2018 Earnings Conference Call Transcript

2019-02-06 17:11:18 | Edited Transcript of BSX earnings conference call or presentation 6-Feb-19 1:00pm GMT

2019-02-06 16:46:50 | Snap and Capri Holdings rise while Electronic Arts tumbles

2019-02-06 16:35:54 | This Highly Rated Medtech Is Staring Down A Buy Point After Earnings Beat

2019-02-06 16:04:09 | Boston Scientific BSX Beats on Q4 Earnings, Margins Dip

2019-02-06 16:02:01 | Stocks end lower amid mixed corporate earnings

2019-02-06 14:43:23 | Boston Scientific Rises on 4th-Quarter Results

2019-02-06 13:36:06 | Final Trades: eBay, Twitter, L Brands, Boston Scientific, & McKesson

2019-02-06 10:12:06 | Stocks Turn Lower, But These Top Stocks Break Out On Earnings